Direct Flow Medical takes $40M for heart valve treatments
Direct Flow Medical, maker of a minimally-invasive device to treat heart valve disease, has raised $40 million of a targeted $42.5 million third round of venture funding, according to a filing with the SEC. Based in Santa Rosa, Calif., the company is backed by Johnson & Johnson Development Corp., Foundation Medical Partners, VantagePoint Venture Partners, ePlanet Ventures, EDF Ventures, New Leaf Venture Partners and Spray Venture Partners. It has raised $75 million to date.
Next Story: Review: First look at Microsoft’s Windows Mobile 6.5 on the HTC Pure cell phone
Previous Story: Google lands energy device partner, doesn’t have to wait for smart meters
Tags: co:Direct-Flow-Medical, inv:EDF-Ventures, inv:ePlanet-Ventures, inv:Foundation-Medical-Partners, inv:Johnson-&-Johnson-Development-Corp., inv:New-Leaf-Venture-Partners, inv:Spray-Venture-Partners, inv:VantagePoint-Venture-Partners
Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.
With GreenBeat 2009, VentureBeat's all-star conference on all things Smart Grid, coming up in November, Camille will be expanding coverage of this exciting space. Stay up to date by following @greenbeat2009 on Twitter or by becoming a fan of the event on Facebook here.